Institutional investors purchased a net $20.0 thousand shares of ORMP during the quarter ended May 2016. This may signal that the smart money is gaining interest in this company as the 1.69% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 29.3 Thousand shares of Oramed Pharmaceuticals In...